SKB107
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SKB107, covering 2025-12-08 to 2025-12-08. Get the full timeline:
Most recent: Clinical Trial Update: A Study of SKB107 in Advanced Solid Tumors With Bone Metastases [Phase 1]